about
Cortical metabolic arrangement during olfactory processing: proposal for a 18F FDG PET/CT methodological approach.Cortico-subcortical metabolic correlates of olfactory processing in healthy resting subjects.May positron emission tomography reveal ectopic or active thymus in preoperative evaluation of non-thymomatous myasthenia gravis?SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases.Brain imaging in glaucoma from clinical studies to clinical practice.Single-photon emission computed tomography/computed tomography in brain tumors.Indium111 pentetreotide single photon emission computed tomography (In111 pentetreotide SPECT): a new technique to evaluate somatostatin receptors in chordomas.Hybrid SPECT/CT Imaging in the Evaluation of Coronary Stenosis: Role in Diabetic PatientsFunctional and ultrastructural evidence of myocardial stunning after acute carbon monoxide poisoning.Early and phasic cortical metabolic changes in vestibular neuritis onset.Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study.Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.Cerebellar metabolic involvement and its correlations with clinical parameters in vestibular neuritis.Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy.The role of (18)F-FDG positron emission tomography in the follow-up of liver tumors treated with (90)Yttrium radioembolization.Fusion imaging in nuclear medicine--applications of dual-modality systems in oncology.Functional-anatomical image fusion in neuroendocrine tumors.Involvement of Subcortical Brain Structures During Olfactory Stimulation in Multiple Chemical Sensitivity.Initial staging of Hodgkin's disease: role of contrast-enhanced 18F FDG PET/CT[99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.99mTc labelled cationic lipophilic complexes in malignant and benign tumors: the role of SPET and pinhole-SPET in breast cancer, differentiated thyroid carcinoma and hyperparathyroidism.MRI and bone scan imaging in the preoperative evaluation of painful vertebral fractures treated with vertebroplasty and kyphoplasty.Early cortical metabolic rearrangement related to clinical data in idiopathic sudden sensorineural hearing loss.Rare lymphoid malignancies of the breast: report of two cases illustrating potential diagnostic techniquesSingle-photon emission computed tomography/computed tomography in abdominal diseases.Muscular uptake of Tc-99m MIBI and TI-201 in Duchenne muscular dystrophy.Molecular imaging of atheroslerotic plaque with nuclear medicine techniques.Reverse perfusion pattern in myocardial spect with 99mTc-sestaMIBI.Hybrid imaging systems in the diagnosis of osteomyelitis and prosthetic joint infection.Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer.Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity.Molecular imaging and magnetic resonance imaging in early diagnosis of Alzheimer's disease. A literature review.Molecular breast imaging with gamma emitters.WIDEN: A tool for medical image management in multicenter clinical trials.Bio-Distribution, Imaging Protocols and Diagnostic Accuracy of PET with Tracers of Lipogenesis in Imaging Prostate Cancer: a Comparison between 11C-Choline, 18FFluoroethylcholine and 18F-Methylcholine.Metabolic and clinical assessment of efficacy of cryoablation therapy on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analogue scale (VAS): initial experience.High-resolution gamma-camera for molecular breast imaging: First clinical results.Clinical impact of extrapleural pneumonectomy for malignant pleural mesothelioma.TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice.Time to and risk of cardiac events after myocardial perfusion scintigraphy.
P50
Q30400446-82455033-0274-4D9B-98A7-FDC1E453BEF1Q30436870-3EB98E20-8E50-4DC7-BB17-454100B7C6E4Q30587645-86B9A857-853E-4464-9AD6-0C0C56DE3814Q30828977-50D014F2-81C8-4072-999D-E591A617DCCAQ31013523-C92BD3B8-90A1-4EB1-A681-D500E3FF4DCDQ31084638-0EDE2DC4-5B43-4534-9EE2-976BB32C4D4FQ33272347-67D160FF-976D-485A-A467-2F7D660D338FQ33711221-6BE65EBF-9D47-4459-8AFC-2E39E192612EQ34465505-3EBE5C2F-CFCA-4728-9F75-D54C9CBF0913Q34625553-39454D56-F868-4048-9B59-073C34BF5EA7Q34993792-FA005CD2-06E2-42EB-8557-B8EA62D4C7C9Q35155500-66E1D944-B35A-4B56-AA0A-5136442E0BC2Q35216928-3E249CAD-4F0A-45FC-B065-BDF06AD02317Q35594594-207A2215-FCE7-4332-99D6-A42A7C7AB3E2Q35656582-E5CB3487-10F3-4EB7-A986-2A370D32C569Q35739756-560F0D7C-EF03-4A15-B61E-266F565E67B3Q35739761-B767D476-CA09-4180-BB73-B80058DCCD79Q35799867-03718BD7-1533-4669-99A0-60FA402F20EBQ36150877-0BCAE4E9-0A47-4770-A501-1D4763C41A36Q36190337-194E9CA4-BCD7-4CFD-A412-7E5F0015B3E8Q36190343-1393F220-3EAE-407F-AB7B-B5AC4256C68AQ36309158-541B2E0F-CC90-49C4-8CD7-609D21EF6B30Q36359906-1BF10B75-8056-44A3-A042-B6095EC5904AQ36568075-5DE08AE3-BC24-4EBF-9FFD-3257496AD639Q36679661-C5B74B88-79E5-4903-88F6-1424F4F91E7DQ36830180-628BC7AE-1136-48F2-8E83-FE8EE7D6E17BQ37198981-A4E666B7-81C2-4031-8BAD-24C066ED8A90Q37206197-07910E9D-B739-4747-B3F2-834D9A3E8F93Q37381657-B4458D95-226F-411B-A803-E4A1FB79D325Q37991832-33931F24-0AAF-4C8F-BC24-1D6091CB533FQ38017331-1F30744A-0BF8-48BD-A373-03AB12821545Q38164472-986B4D3A-C72E-496D-A9AB-5BC2CBD6E59BQ38169948-A2A43ACD-1717-47D5-8629-5A81055D19F3Q38202946-1E096D63-40C9-4904-AE19-E5CEE3953A2CQ38568691-8381687C-E451-45EB-8369-07A3B17DA083Q39285633-C2F93C02-DF26-4BFC-A296-DAE42C79DD1EQ40190890-AD0E3B77-0864-4B22-8194-29C39CCF0C00Q40301690-A0248AC8-617E-4C37-B588-3D06FE458F25Q40666812-156A5C2A-6998-4A73-B26A-E519DB4B54D8Q41572361-CE365DEC-0AB6-4E69-9380-F7C10727C799
P50
description
researcher ORCID ID = 0000-0002-6176-2805
@en
wetenschapper
@nl
name
Orazio Schillaci
@ast
Orazio Schillaci
@en
Orazio Schillaci
@es
Orazio Schillaci
@nl
type
label
Orazio Schillaci
@ast
Orazio Schillaci
@en
Orazio Schillaci
@es
Orazio Schillaci
@nl
prefLabel
Orazio Schillaci
@ast
Orazio Schillaci
@en
Orazio Schillaci
@es
Orazio Schillaci
@nl
P106
P1153
7006797595
P31
P496
0000-0002-6176-2805